Daniel Chandramohan MBBS MSc PhD

- 414
- LSHTM
- Keppel Street
- London
- WC1E 7HT
- T: 0207 927 2322
- F: 0207 927 2918
Affiliation
Research areas
- Drug resistance
- Micronutrients
- Surveillance
Disciplines
- Epidemiology
Disease and Health Conditions
- Malaria
- Meningitis
-
Selected publications
-
Efficay, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial
Tagbor, H; Bruce, J; Brown, E; Randal, A;Greenwood, B; Chandramohan, D
Lancet, In Press;
-
Intermittent preventive treatment of malaria in infants: how does it work and where will it work?
Gosling, R.D.; Carneiro, I.; Chandramohan, D.;
Trop Med Int Health, 2009; 14(9):1003-10
-
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial
Gosling, R.D.; Gesase, S.; Mosha, J.F.; Carneiro, I.; Hashim, R.; Lemnge, M.; Mosha, F.W.; Greenwood, B.; Chandramohan, D.
Lancet, 2009;
-
A Randomized, Controlled Trial of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine, Amodiaquine, or the Combination in Pregnant Women in Ghana.
Clerk, C.A.; Bruce, J.; Affipunguh, P.K.; Mensah, N.; Hodgson, A.; Greenwood, B.; Chandramohan, D.;
J Infect Dis, 2008; 198(8):1202-11
-
A new approach to the definition of seroconversion following vaccination in a population with high background antibody concentrations.
Chandramohan, D.; Coleman, P.; Nelson, C.; Greenwood, B.;
Vaccine, 2007; 25S1:A58-A62
-
Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
Tagbor, H.; Bruce, J.; Browne, E.; Randal, A.; Greenwood, B.; Chandramohan, D.;
Lancet, 2006; 368(9544):1349-56
- → View all Daniel Chandramohan's publications
